MarketPR
ENERGYCincinnati defeats No. 8 Texas Tech 37-24 in Big 12 upsetOct 24WORLDNeil Bush backs Texas Democrat Talarico in Senate raceOct 24PRODUCTKate Gosselin says her kids know who she truly is as son Collin levels abuse allegationsOct 24WORLDOmar's deleted tweet could give clue on alleged brother marriageOct 24DEALSFive dividend stocks yield over 5% despite current headwindsOct 24MARKETSFour historical indicators signal potential stock market crashOct 24WORLDTrump Advisers See Middle East Opportunities Beyond NetanyahuOct 24CRYPTOAI-generated Jon Bon Jovi videos trick Louisiana woman into $10K lossOct 24WORLDLawmakers urge AI leaders to stop warning of existential doomOct 24REGULATORYIlhan Omar admits uncertainty on family ties amid immigration fraud probeOct 24ENERGYCincinnati defeats No. 8 Texas Tech 37-24 in Big 12 upsetOct 24WORLDNeil Bush backs Texas Democrat Talarico in Senate raceOct 24PRODUCTKate Gosselin says her kids know who she truly is as son Collin levels abuse allegationsOct 24WORLDOmar's deleted tweet could give clue on alleged brother marriageOct 24DEALSFive dividend stocks yield over 5% despite current headwindsOct 24MARKETSFour historical indicators signal potential stock market crashOct 24WORLDTrump Advisers See Middle East Opportunities Beyond NetanyahuOct 24CRYPTOAI-generated Jon Bon Jovi videos trick Louisiana woman into $10K lossOct 24WORLDLawmakers urge AI leaders to stop warning of existential doomOct 24REGULATORYIlhan Omar admits uncertainty on family ties amid immigration fraud probeOct 24
NewsEarnings · AAPL

TOI in focus as The Oncology Institute sets Q2 2026 earnings date and conference call

A Q2 2026 earnings date is now on the calendar for The Oncology Institute (NASDAQ: TOI), with an investor conference call attached. The Cerritos, California-based community oncology company made the announcement July 27, 2026, through GlobeNewswire. For investors following this name, the print is the next confirmable event.

By Renata OstrowskiNewsroomJuly 27, 20262 min readAAPL
Share

Key takeaways

  • The Oncology Institute (NASDAQ: TOI) has scheduled a date to release its second quarter 2026 financial results and host an investor conference call.
  • The Cerritos, California-based community oncology company announced the earnings date on July 27, 2026, via GlobeNewswire.
  • The July 27 notice included no preliminary financial figures, no speaker list, and no dial-in details.
  • TOI describes itself as a pioneer in value-based community oncology care, using its own language from the filing.
  • The Q2 2026 earnings release remains the definitive next input for investors, with the figures still outstanding.

A Q2 2026 earnings date is now on the calendar for The Oncology Institute (NASDAQ: TOI), with an investor conference call attached. The Cerritos, California-based community oncology company made the announcement July 27, 2026, through GlobeNewswire. For investors following this name, the print is the next confirmable event.

The announcement

The Oncology Institute, Inc. says it will release second quarter 2026 financial results and host a conference call for investors and analysts. The July 27 notice carried no preliminary figures, no speaker list, and no dial-in details. The release establishes the format and the commitment. The numbers come with the print.

What this means for the setup

TOI describes itself as a pioneer in value-based community oncology care. That framing is the company's own language from the filing. No financial specifics appear in the scheduling notice itself, and the announcement carries no signals on the direction of the quarter.

What to watch

The earnings release is the definitive next input for investors in TOI. The conference call that follows gives management the venue to address Q2 conditions and take analyst questions directly. Both are now scheduled. The Q2 figures remain the only thing still outstanding.

Related reading

About this story

Filed by the newsroom of MarketPR on July 27, 2026. Source: markets.businessinsider.com. Indicative figures are not investment advice.

←Back to the news index

More from the Newsroom

All stories →
01Earnings

Astera Labs launches PCIe 7 chips and Orion racks after 15% drop

Astera Labs (ALAB) released its Aries 7 signal-conditioning chips and Orion rack-scale reference design during a week when the stock fell more than 15%, following a broad sell-off in artificial intelligence equities. The company, which…

Talia Greenwood2 min read
02Earnings

AT&T lifts EPS outlook on Mexico sale, shares drop

AT&T (T) shares declined 6.4% on October 21, 2026, following the company's report of fiscal third-quarter results. The drop occurred even as the S&P 500 rose 0.6% during the same session. Management raised its full-year adjusted earnings…

Talia Greenwood2 min read
03Earnings

Rangers vs. Maple Leafs preview favors the under as both teams tighten defensively

The New York Rangers and Toronto Maple Leafs meet in a matchup where defensive constraints are expected to limit scoring, with analysts favoring the under 6.5 total. The Rangers enter the game with a 7-3-1 record, while the Maple Leafs sit…

Talia Greenwood2 min read

Frequently asked

When did The Oncology Institute announce its Q2 2026 earnings date?

The company made the announcement on July 27, 2026, through GlobeNewswire.

What financial details were included in the announcement?

None; the notice carried no preliminary figures, no speaker list, and no dial-in details, only establishing the format and commitment to report.

Where is The Oncology Institute based and what does it do?

It is based in Cerritos, California, and is a community oncology company that describes itself as a pioneer in value-based community oncology care.

What is TOI's stock ticker and exchange?

The Oncology Institute trades on the NASDAQ under the ticker TOI.

What should investors watch next for TOI?

The Q2 2026 earnings release and the conference call that follows, where management can address quarterly conditions and take analyst questions.